400
Views
22
CrossRef citations to date
0
Altmetric
Treatment

The Effect of Intranasal Corticosteroids on Asthma Control and Quality of Life in Allergic Rhinitis with Mild Asthma

, M.D., , M.D., , Ph.D., , Ph.D., , Ph.D., , M.D., , M.D., , M.D., , M.D. & , M.D. show all
Pages 41-47 | Published online: 04 Nov 2010

References

  • Passalacqua G, Ciprandi G, Canonica GW. The nose-lung interaction in allergic rhinitis and asthma: United airways disease. Curr Opin Allergy Clin Immunol 2001; 1(1):7–13.
  • Blaiss MS. Rhinitis-asthma connection: Epidemiologic and pathophysiologic basis. Allergy Asthma Proc 2005; 26(1):35–40.
  • Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000; 106(5 Suppl):S201–S205.
  • Linneberg A, Henrik Nielsen N, Frolund L, Madsen F, Dirksen A, Jorgensen T. The link between allergic rhinitis and allergic asthma: A prospective population-based study. The Copenhagen Allergy Study. Allergy 2002; 57(11):1048–1052.
  • Braunstahl GJ, Fokkens W. Nasal involvement in allergic asthma. Allergy 2003; 58(12):1235–1243.
  • Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy 2003; 58(8):691–706.
  • Fontanari P, Burnet H, Zattara-Hartmann MC, Jammes Y. Changes in airway resistance induced by nasal inhalation of cold dry, dry, or moist air in normal individuals. J Appl Physiol 1996 Oct; 81(4):1739–1743.
  • Togias A. Mechanisms of nose-lung interaction. Allergy 1999; 54(Suppl 57):94–105.
  • Braunstahl GJ, Fokkens WJ, Overbeek SE, KleinJan A, Hoogsteden HC, Prins JB. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: A comparison between upper and lower airways. Clin Exp Allergy 2003; 33(5):579–587.
  • Braunstahl GJ, Hellings PW. Allergic rhinitis and asthma: The link further unraveled. Curr Opin Pulm Med 2003; 9(1):46–51.
  • Togias A. Rhinitis and asthma: Evidence for respiratory system integration. J Allergy Clin Immunol 2003; 111(6):1171–1183.
  • Bousquet J, Gaugris S, Kocevar VS, Zhang Q, Yin DD, Polos PG, Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: A subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy. Clin Exp Allergy 2005; 35(6):723–727.
  • Lasmar LM, Camargos PA, Ordones AB, Gaspar GR, Campos EG, Ribeiro GA. Prevalence of allergic rhinitis and its impact on the use of emergency care services in a group of children and adolescents with moderate to severe persistent asthma. J Pediatr 2007; 83(6):555–561.
  • American Thoracic Society Workshop. Medical Selection of the American Lung Association. Immunobiology of asthma and rhinitis: Patogenetic factor and therapeutic options. Am J Respir Crit Care Med 1999; 160:1778–1787.
  • Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63(Suppl 86):8–160.
  • Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: The risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002; 109(1):57–62.
  • Fuhlbrigge AL, Adams RJ. The effect of treatment of allergic rhinitis on asthma morbidity, including emergency department visits. Curr Opin Allergy Clin Immunol 2003; 3(1):29–32.
  • Henriksen JM, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis 1984; 130(6):1014–1018.
  • Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992; 90(2):250–256.
  • Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: Effect on lower airway responsiveness. J Allergy Clin Immunol 1993; 91:97–101.
  • Agondi RC, Machado ML, Kalil J, Giavina-Bianchi P. Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptoms. J Asthma 2008; 45(9):754–757.
  • Pedersen W, Hjuler I, Bisgaard H, Mygind N. Nasal inhalation of budesonide from a spacer in children with perennial rhinitis and asthma. Allergy 1998; 53(4):383–387.
  • Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001; 107(3):469–476.
  • Ciprandi G, Tosca MA, Cirillo I, Vizzaccaro A. The effect of budesonide on the cytokine pattern in patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol 2003 Nov; 91(5):467–471.
  • Global INitiative for Asthma (GINA).Global strategy for asthma management and prevention:NHLBI/WHO workshop report. National Heart, Lung and Blood Institute, Bethesda, MD. Updated 2006.
  • Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Development of the asthma control test: A survey for assessing asthma control. J Allergy Clin Immunol 2004; 113(1):59–65.
  • Baiardini I, Pasquali M, Giardini A, Specchia C, Passalacqua G, Venturi S, Rhinasthma: A new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003; 58(4):289–294.
  • Pellegrino R, Decramer M, van Schayck CP, Dekhuijzen PN, Troosters T, van Herwaarden C, Quality control of spirometry: A lesson from the BRONCUS trial. Eur Respir J 2005 Dec; 26(6):1104–1109.
  • Stelmach R, do Patrocinio TNM, Ribeiro M, Cukier A. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest 2005; 128(5):3140–3147.
  • Pelucchi A, Chiapparino A, Mastropaqua B, Marazzini L, Hernandez A, Foresi A. Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacoline in allergic rinitis in response to grasse pollens. J Allergy Clin Immunol 1995; 95:515–523.
  • Dahl R, Baker R, Pauwels R. Seasonal rhinitis and asthma effects of topical nasal and/or orally invale fluticasone propionate. J Allergy Clin Immunol 2001; 107:S154.
  • Braunstahl GJ, Overbeek SE, Fokkens WJ, Kleinjan A, McEuen AR, Walls AF, Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001; 164(5):858–865.
  • Sanico AM, Atsuta S, Proud D, Togias A. Plasma extravasation through neuronal stimulation in human nasal mucosa in the setting of allergic rhinitis. J Appl Physiol 1998; 84(2):537–543.
  • Sanico AM, Philip G, Proud D, Naclerio RM, Togias A. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: Effects of capsaicin nasal challenge. Clin Exp Allergy 1998; 28(1):92–100.
  • Hamid QA. Peripheral inflammation is more important than central inflammation. Respir Med 1997; 91(Suppl A):11–12.
  • Crimi E, Milanese M, Oddera S, Mereu C, Rossi GA, Riccio A, Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis. J Appl Physiol 2001; 91(3):1029–1034.
  • van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 2006; 27(5):951–956.
  • in 't Veen JC, Beekman AJ, Bel EH, Sterk PJ. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Res Crit Care Med 2000; 161(6):1902–1906.
  • Lee YM, Park JS, Hwang JH, Park SW, Uh ST, Kim YH, High-resolution CT findings in patients with near-fatal asthma: Comparison of patients with mild-to-severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 2004; 126(6):1840–1848.
  • TakedaT, OgaT, NiimiA, MatsumotoH, ItoI, YamaguchiM, Relationship between small airway function and health status, dyspnea and disease control in asthma Respiration. 2010; 80(2):120–126.
  • Howarth PH, Persson CG, Meltzer EO, Jacobson MR, Durham SR, Silkoff PE. Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol 2005; 115(3 Suppl 1):S414–S441.
  • Barraza-Villarreal A, Sunyer J, Hernandez-Cadena L, Escamilla-Nuñez MC, Sienra-Monge JJ, Ramírez-Aguilar M, Air pollution, airway inflammation, and lung function in a cohort study of Mexico city schoolchildren. Environ Health Perspect 2008; 116(6):832–838.
  • Hanf G, Noga O, O'Connor A, Kunkel G. Omalizumab inhibits allergen challenge-induced nasal response. Eur Respir J 2004; 23(3):414–418.
  • Krakowiak A, Walusiak J, Krawczyk P, Wiszniewska M, Dudek W, Wittczak T, IL-18 levels in nasal lavage after inhalatory challenge test with flour in bakers diagnosed with occupational asthma. Int J Occup Environ Health 2008; 21(2):165–172.
  • Ciprandi G, Cirillo I, Klersy C, Marseglia GL, Vizzaccaro A, Pallestrini E, Role of FEF25-75 as an early marker of bronchial impairment in patients with seasonal allergic rhinitis. Am J Rhinol 2006; 20(6):641–647.
  • Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life instrument. J Clin Epidemiol 1994; 47:81–87.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.